OptiBiotix Health Plc (LON:OPTI – Get Free Report) rose 8.8% on Thursday . The company traded as high as GBX 15.52 ($0.20) and last traded at GBX 15.50 ($0.20). Approximately 286,268 shares changed hands during mid-day trading, a decline of 11% from the average daily volume of 320,743 shares. The stock had previously closed at GBX 14.25 ($0.18).
OptiBiotix Health Stock Performance
The business has a 50 day moving average price of GBX 13.55 and a two-hundred day moving average price of GBX 18.07. The stock has a market cap of £15.77 million, a P/E ratio of -437.90 and a beta of 1.71. The company has a quick ratio of 7.89, a current ratio of 6.18 and a debt-to-equity ratio of 4.51.
About OptiBiotix Health
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
See Also
- Five stocks we like better than OptiBiotix Health
- Best Aerospace Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Ride Out The Recession With These Dividend Kings
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
